Exact Sciences provides Oncotype DX testing for Gloucestershire Hospitals
- Gloucestershire Hospitals NHS Foundation Trust
- South West
- 1 bid
Gloucestershire Hospitals NHS Foundation Trust bought the Oncotype DX Breast Recurrence Score test from Exact Sciences. The genomic assay is a send-away test that gives a personal view of each patient's breast cancer biology.
Exact Sciences was the only bidder, and the lowest price decided the award. The trust awarded the £229,500 contract in October 2026, for a 12-month term.
- What
- Pathology and specialist laboratory testing services
- Supplier
- Exact Sciences
- Value
- £229,500
- How it was bought
- Not published
- 1 bid
- Dates and next
- 7 Oct 2026